Indications |
Oral Onchocerciasis Adult: ≥15 kg: 150 mcg/kg as a single dose; retreatment may be given every 6-12 mth until adult worms die. Child: >5 yr and ≥15kg: 150 mcg/kg as a single dose every 6-12 mth until adult worms die. Oral Strongyloidiasis Adult: 200 mcg/kg as a single dose for 1-2 days. Child: >15 kg: 200 mcg/kg as a single dose for 1-2 days. Oral Filariasis Adult: Dosing regimen depends on the causative agent. Mansonella streptocerca 150 mcg/kg as a single dose; Mansonella ozzardi 200 mcg/kg as a single dose. Child: ≥15 kg: Dosing regimen depends on the causative agent. Mansonella streptocerca 150 mcg/kg as a single dose; Mansonella ozzardi 200 mcg/kg as a single dose. Oral Ascariasis Adult: Ascaris lumbricoides 150-200 mcg/kg as a single dose. Child: ≥15 kg: Ascaris lumbricoides 150-200 mcg/kg as a single dose. Oral Gnathostomiasis Adult: Gnathostoma spinigerum: 200 mcg/kg once daily for 2 days. Child: ≥15 kg: Gnathostoma spinigerum: 200 mcg/kg once daily for 2 days. Oral Scabies Adult: Sarcoptes scabiei 200 mcg/kg as a single dose, repeat dose in 2 wk. Child: ≥15 kg: Sarcoptes scabiei 200 mcg/kg as a single dose, repeat dose in 2 wk. |
Contraindications |
Hypersensitivity. Pregnancy and lactation. Childn <15 kg body weight. |
Warnings / Precautions |
Concurrent Loa loa infection, impaired blood-brain barrier function due to infection. |
Adverse Reactions |
Diarrhoea, nausea, vomiting, dizziness, pruritus, urticaria, rash, arthralgia, fever, myalgia, asthenia, postural hypotension, tachycardia, oedema, lymphadenopathy, sore throat, cough, headache, somnolence, transient eosinophilia, raised liver enzyme values. |
Drug Interactions |
Bioavailability may be increased by alcohol, levamisole. See Below for More ivermectin Drug Interactions |
Food Interactions |
Orange juice slightly reduces bioavailability of ivermectin. |
Mechanism of Actions |
Ivermectin selectively binds and with high affinity to glutamate-gated chloride ion channels, which occur in invertebrate nerve and muscle cells leading to an increase in the permeability of cell membranes to chloride ions with hyperpolarization of the nerve or muscle cell and, ultimately, death of the parasite. Absorption: Absorbed from the GI tract (oral); peak plasma concentrations after 4 hr. Distribution: Enters breast milk (<2%). Protein-binding: About 93%. Excretion: Via faeces (as metabolites), via urine (<1%). Plasma elimination half-life: 12 hr. |
Administration |
Should be taken on an empty stomach. (Take on an empty stomach.) |
ATC Classification |
P02CF01 - ivermectin ; Belongs to the class of avermectine agents. Used as antinematodal. |
Available As |
|
Ivermectin
Post Review about Ivermectin Click here to cancel reply.
Ivermectin Containing Brands
Ivermectin is used in following diseases
Drug - Drug Interactions of Ivermectin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.